AJP - Heart AJP: Lung Cellular and Molecular Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (March 16, 2007). doi:10.1152/ajpheart.01418.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/1/H489    most recent
01418.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grad, E.
Right arrow Articles by Danenberg, H. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grad, E.
Right arrow Articles by Danenberg, H. D
Submitted on December 27, 2006
Accepted on March 14, 2007

Transgenic expression of human C-reactive protein suppresses endothelial nitric oxide synthase expression and bioactivity following vascular injury

Etty Grad1, Mordechai Golomb1, Irit Mor Yosef1, Nikolay Koroukhov1, Chaim Lotan1, Elazer Reuven Edelman2, and Haim D Danenberg3*

1 Cardiology, Hadassah Hebrew Univesity Medical Center, Jerusalem, Israel
2 Health Sciences and Technology, Harvard-MIT, Cambridge, Massachusetts, United States
3 Cardiology, Hadassah Hebrew University Medical Center, Israel

* To whom correspondence should be addressed. E-mail: danen{at}md.huji.ac.il.

Objective: C-reactive protein (CRP) is a risk marker and a potential modulator of vascular disease. It remains unclear as to whether CRP modulates nitric oxide synthase (NOS) activity and nitric oxide (NO) metabolism. We studied the effect of CRP on NO metabolism in transgenic mice that express human CRP (CRPtg). Methods and Results: CRPtg and wildtype mice underwent controlled femoral artery wire injury. CRP serum levels in CRPtg at baseline, 6h and 24 h after injury were 12.4±9, 18.6±6.9 and 58.4±13 mg/L, respectively while undetectable in all time points in wildtypes. Endothelial NOS (eNOS) protein and mRNA expression were significantly suppressed in the injured arteries of CRPtg mice (n=5, p<0.05). Similar reduction in eNOS expression was observed in the distant lung and heart. NO release post injury was significantly lower in CRPtg as measured by nitrate and nitrite breakdown products with a concomitant suppression of cyclic GMP NO signaling post- injury. Conclusions: eNOS and NO expression following vascular injury are locally and systemically suppressed in mice that express human CRP. These in vivo observations support the hypothesis that CRP modulates NO metabolism and may have implications regarding the mechanisms by which CRP modulates vascular disease.




This article has been cited by other articles:


Home page
ChestHome page
E. K. Bajwa, U. A. Khan, J. L. Januzzi, M. N. Gong, B. T. Thompson, and D. C. Christiani
Plasma C-Reactive Protein Levels Are Associated With Improved Outcome in ARDS
Chest, August 1, 2009; 136(2): 471 - 480.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. J. Ho, C. D. Owens, T. Longo, X. X. Sui, C. Ifantides, and M. S. Conte
C-reactive protein and vein graft disease: evidence for a direct effect on smooth muscle cell phenotype via modulation of PDGF receptor-{beta}
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1132 - H1140.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.